Express News | Taysha Gene Therapies Files for Mixed Shelf Offering of up to $300 Mln - SEC Filing

BreakingsDec 14 05:07

Express News | Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

BreakingsDec 6 21:00

JMP Securities Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $5

Futu NewsNov 22 08:32 · Ratings

Buy Rating for Taysha Gene Therapies Due to Safer Administration Method and Lower Viral Dose

TipRanksNov 22 07:55 · Ratings

Taysha Gene Therapies Analyst Ratings

BenzingaNov 15 22:30 · Ratings

CCORF Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Raises Target Price to $8

Futu NewsNov 15 20:33 · Ratings